Aquaporin-4 and Lung Cancer
Author Information
Author(s): Warth Arne, Muley Thomas, Meister Michael, Herpel Esther, Pathil Anita, Hoffmann Hans, Schnabel Philipp A, Bender Christian, Buness Andreas, Schirmacher Peter, Kuner Ruprecht
Primary Institution: University Hospital Heidelberg, Germany
Hypothesis
The study investigates the expression of aquaporins in non-small cell lung cancer (NSCLC) and their potential as therapeutic targets.
Conclusion
Higher expression of AQP4 in well-differentiated lung adenocarcinomas is associated with a more favorable prognosis.
Supporting Evidence
- AQP1, -3, -4, and -5 were found to be differentially expressed in NSCLC compared to normal lung tissues.
- Higher AQP4 expression was associated with better prognosis in adenocarcinoma patients.
- Immunohistochemical analysis confirmed AQP4 protein expression predominantly in well-differentiated adenocarcinomas.
- Data mining revealed AQP4's involvement in cell signaling and lipid metabolism.
Takeaway
This study looks at how a protein called AQP4 behaves in lung cancer and finds that more of it might mean a better chance of survival.
Methodology
The study analyzed AQP expression in 576 lung samples using microarray data, validated by qRT-PCR and immunohistochemistry.
Limitations
The study is limited by the differences in cellular composition between normal lung and NSCLC samples.
Participant Demographics
Patients with non-small cell lung cancer (NSCLC) and matched normal lung tissues.
Statistical Information
P-Value
0.0000
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website